Biomerica Inc SEC filings BMRA
Biomerica Inc has 605 filings in SEC EDGAR's recent list, going back to Sep 28, 1995. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 15, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Sep 24, 2026 | — |
| S-3 | Shelf registration | Sep 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| S-8 | Employee stock plan registration | Dec 20, 2024 | — |
| S-8 | Employee stock plan registration | Nov 25, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| S-3 | Shelf registration | Sep 28, 2023 | — |
| 424B5 | Prospectus supplement | Mar 7, 2023 | — |
| 424B5 | Prospectus supplement | Mar 2, 2023 | — |
| 424B5 | Prospectus supplement | Mar 2, 2023 | — |
| S-8 | Employee stock plan registration | May 21, 2021 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| S-3/A | Form s-3/a | Sep 11, 2020 | — |
| S-3 | Shelf registration | Jul 21, 2020 | — |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| S-8 | Employee stock plan registration | May 10, 2018 | — |
| 424B5 | Prospectus supplement | Dec 4, 2017 | — |
| S-3 | Shelf registration | Jun 30, 2017 | — |
| S-8 | Employee stock plan registration | May 22, 2015 | — |
| S-8 | Employee stock plan registration | Feb 9, 2012 | — |
| S-8 | Employee stock plan registration | May 30, 2007 | — |
| S-4 | Registration for a merger or exchange | Apr 12, 2002 | — |
| S-8 | Employee stock plan registration | Mar 29, 2000 | — |
| 424B3 | Prospectus | Jun 23, 1998 | — |
| S-3/A | Filing | Oct 8, 1997 | — |
| S-3 | Shelf registration | Jan 17, 1997 | — |
| S-8 | Employee stock plan registration | Jan 11, 1996 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- BMRA (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 73290
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.